Clivus chordomas: a systematic review and meta-analysis of contemporary surgical management.

医学 斜坡 脊索瘤 外科 入射(几何) 人口 颅骨 环境卫生 光学 物理
作者
Moujahed Labidi,Kentaro Watanabe,S. Bouazza,Damien Bresson,Anne Laure Bernat,Bernard George,Sébastien Froelich
出处
期刊:PubMed 卷期号:60 (4): 476-84 被引量:59
链接
标识
摘要

Chordomas are rare bony lesions arising from notochordal remnants. Technical advances in endoscopic surgery have allowed the median endonasal corridor to be used for a larger number of chordoma cases. However, very few studies have critically examined the data in support of the anterior midline approach (AMA), as compared to lateral and posterolateral transcranial corridors.A systematic search of the literature was done in March 2016 using EMBASE and PubMed for articles published between January 2006 and March 2016 to identify surgical series of clivus chordomas. Only articles describing chordomas cases arising from the clivus of craniocervical junction were included in the analysis.Twenty-seven articles were included in this systematic review, amounting to a total of 1050 patients. The weighted mean rate of GTR was 39.9% (range 0-78.3%) in this patient population. The surgical approaches were described in 16 papers, with 6 series reporting on surgeries done exclusively through the midline corridor (116 patients). In the remaining 10 series (495 patients), the AMA was used in a mean of 56.8% of cases. In studies including patients operated solely through an AMA, a higher GTR rate was obtained (60.7% vs. 42.0%). Postoperative complications were also different between the two cohorts, with lower cranial nerves deficits and CNS infections but higher incidence of CSF leak in the AMA group than in mixed surgical series. In a weighted mean follow-up time of 52.1±21.9 months, recurrences were observed in 38.2% of the total population of patients. Among 423 patients, the weighted 5-year PFS was 49.9±12.1% and the 5-year OS was 73.9±11.2% (N.=391). A random effects model was performed, combining data from studies reporting recurrence rates in GTR and non-GTR (N.=610), with a total odds ratio of having a recurrence for patients who had GTR vs non-GTR of 0.289 (95CI 0.184-0.453).In this systematic review and meta-analysis of studies published in the last decade, an estimated 5-year PFS of 49.9% and 5-year OS of 73.9% were obtained. The weighted mean GTR rate in the included study was 39.9%, with a significantly reduced occurrence of recurrence in complete resections. Although anterior midline approaches may allow for higher GTR rates and fewer neurological morbidity than traditional transcranial routes, their impact of long-term survival and disease control remains largely unknown.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小皮猪发布了新的文献求助30
刚刚
莉莉娅89完成签到,获得积分10
2秒前
十三完成签到,获得积分10
2秒前
3秒前
海上溜冰完成签到 ,获得积分10
3秒前
栗子完成签到,获得积分10
3秒前
吕小布完成签到 ,获得积分10
4秒前
小郭完成签到,获得积分10
5秒前
bkagyin应助月初采纳,获得10
6秒前
7秒前
111关闭了111文献求助
7秒前
不配.应助小皮猪采纳,获得20
7秒前
斯文香彤完成签到,获得积分10
8秒前
8秒前
10秒前
10秒前
海上溜冰发布了新的文献求助10
12秒前
不配.应助安静的明辉采纳,获得20
13秒前
削菠萝发布了新的文献求助10
13秒前
14秒前
14秒前
自觉枫发布了新的文献求助10
15秒前
15秒前
112233发布了新的文献求助10
15秒前
15秒前
汉堡包应助limin采纳,获得10
16秒前
16秒前
文闵完成签到,获得积分0
16秒前
轨迹发布了新的文献求助10
16秒前
斯文败类应助体面人采纳,获得200
17秒前
20秒前
陈陈发布了新的文献求助50
20秒前
月初发布了新的文献求助10
20秒前
Ava应助烂漫的猕猴桃采纳,获得10
21秒前
板砖小中医完成签到 ,获得积分10
21秒前
酷酷酷完成签到,获得积分10
21秒前
马德里就思议完成签到,获得积分10
22秒前
24秒前
24秒前
25秒前
高分求助中
Kinetics of the Esterification Between 2-[(4-hydroxybutoxy)carbonyl] Benzoic Acid with 1,4-Butanediol: Tetrabutyl Orthotitanate as Catalyst 1000
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Very-high-order BVD Schemes Using β-variable THINC Method 568
Chen Hansheng: China’s Last Romantic Revolutionary 500
XAFS for Everyone 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3138178
求助须知:如何正确求助?哪些是违规求助? 2789056
关于积分的说明 7790034
捐赠科研通 2445505
什么是DOI,文献DOI怎么找? 1300440
科研通“疑难数据库(出版商)”最低求助积分说明 625925
版权声明 601046